Glycodelin, an immunosuppressive protein with contraceptive properties, is
synthesized by a variety of tissues and cell types. The ability of reproduc
tive tissues to synthesize glycodelin is of major interest in pregnancy and
disease conditions. We studied glycodelin levels in subjects with malignan
t gynecological tumors and in control subjects. Using a polyclonal glycodel
in antibody against the synthetic glycodelin peptide sequence, an enzyme-li
nked immunosorbent assay (ELISA) was devised to measure plasma glycodelin l
evels. The assay detected as much as 5 ng/ml of glycodelin. There was a sig
nificant increase in plasma glycodelin levels in endometrial > ovarian > ce
rvical cancer subjects when compared to those of controls. Strong expressio
n of mRNA and protein were found in the ovarian and endometrial tumor tissu
es. Given glycodelin's immunosuppressive abilities, increased level of glyc
odelin may facilitate tumor growth in gynecological malignancies.